Understanding the metabolic characteristics associated with therapy resistance and uncovering the underpinning mechanisms, such as CD44 and STAT3 crosstalk, will provide insight into novel therapeutic interventions to overcome ovarian cancer chemoresistance. This evidence concerns the gene CD44 and ovarian carcinoma.